Barely Significant
← all excerpts

Uncovering potential molecular biomarkers for cancer-associated secondary lymphedema through integrated analyses of RNA-sequencing, machine learning, and clinical data.

Front Oncol · 2026 · PMC12945810 · PMID 41768256

Europe PMCDOI
1
hedged sentence
0.0100
closest p · 0.2× alpha
0.0100
boldest claim

The sentences

highly significantp < 0.01actually significant
In the breast CASL subgroup, IL2RG, TSPAN1, and HOXD10 were similarly elevated to a highly significant degree ( p < 0.01, Supplementary Figure S1C ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.